Follow
Evangelos Papanastasiou
Evangelos Papanastasiou
HMNC Brain Health
Verified email at hmnc-brainhealth.com - Homepage
Title
Cited by
Cited by
Year
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
P Fusar-Poli, E. Papanastasiou, E. Stahl, D. Rocchetti, M. Carpenter, W ...
Schizophrenia Bulletin, 2014
689*2014
Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial
P Gardner-Sood, J Lally, S Smith, Z Atakan, K Ismail, KE Greenwood, ...
Psychological medicine 45 (12), 2619-2629, 2015
1752015
The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review
E Papanastasiou
Therapeutic Advances in Psychopharmacology 3 (1), 33-51, 2013
1702013
Interventions for the metabolic syndrome in schizophrenia: a review
E Papanastasiou
Therapeutic Advances in Endocrinology and Metabolism 3 (5), 141-162, 2012
822012
Schizophrenia as segmental progeria
E Papanastasiou, F Gaughran, S Smith
Journal of the Royal Society of Medicine 104 (11), 475-484, 2011
402011
Examination of the neural basis of psychotic-like experiences in adolescence during reward processing
E Papanastasiou, E Mouchlianitis, DW Joyce, P McGuire, ...
JAMA Psychiatry, 2018
302018
When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia
E Papanastasiou, JM Stone, S Shergill
The British Journal of Psychiatry 202 (2), 91-93, 2013
272013
Brain-relevant antibodies in first-episode psychosis: a matched case–control study
F Gaughran, J Lally, K Beck, R McCormack, P Gardner-Sood, E Coutinho, ...
Psychological medicine 48 (8), 1257-1263, 2018
262018
Examination of the neural basis of psychotic-like experiences in adolescence during processing of emotional faces
E Papanastasiou, E Mouchlianitis, DW Joyce, P McGuire, C Boussebaa, ...
Scientific Reports 10 (1), 1-11, 2020
82020
Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)?
E Papanastasiou, SS Shergill
Journal of Psychopharmacology 35 (9), 1158-1160, 2021
32021
Psychotic like experiences in healthy adolescents are underpinned by lower fronto-temporal cortical gyrification: a study from the IMAGEN consortium
R Maitra, CM Horne, O O’Daly, E Papanastasiou, C Gaser, ...
Schizophrenia Bulletin 49 (2), 309-318, 2023
22023
Precision psychiatry and Research Domain Criteria: Implications for clinical trials and future practice
LM Williams, WT Carpenter, C Carretta, E Papanastasiou, ...
CNS spectrums, 1-14, 2023
22023
The impact study-Motivating a change in health behaviour
S Smith, K Greenwood, Z Atakan, P Sood, R Ohlsen, E Papanastasiou, ...
European Psychiatry 26 (S2), 2151-2151, 2011
12011
Reduced Fronto-Temporal Cortical Gyrification Associated with Psychotic Like Experiences in Healthy Adolescents
R Maitra, E Papanastasiou, C Gaser, T Banaschewski, GJ Barker, ...
EARLY INTERVENTION IN PSYCHIATRY 12, 165-165, 2018
2018
The neural basis of psychotic-like experiences
E Papanastasiou
King's College London, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–15